KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹14 Cr | ₹20 Cr | ₹29 Cr | ₹21 Cr | ₹28 Cr |
What is the latest Total Non-Current Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹29 Cr |
| Mar2022 | ₹21 Cr |
| Mar2021 | ₹28 Cr |
How is Total Non-Current Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | -30.35 | |
| Mar2024 | ₹20 Cr | -30.98 | |
| Mar2023 | ₹29 Cr | 34.25 | |
| Mar2022 | ₹21 Cr | -24.10 | |
| Mar2021 | ₹28 Cr | - | |
Compare Total Non-Current Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹2,914.2 Cr | 16.8% | 21.3% | 164.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 16.8% |
21.3% |
164.2% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses